Cibus (CBUS) vs Seer (SEER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cibus (CBUS) has outperformed Seer (SEER) over the past year, gaining 13.3% versus a loss of 0.5%. Over five years, SEER leads with a -93.3% price change compared with -98.9% for CBUS. Cibus is the larger company by market cap ($123.8 million vs $122.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBUS | SEER |
|---|---|---|
| Share price | $1.62 | $2.21 |
| Market cap | $123.81M | $122.37M |
| 1-day change | +3.18% | +0.91% |
| YTD return | -6.90% | +20.77% |
| 1-year return | +13.29% | -0.45% |
| 5-year return | -98.90% | -93.30% |
| EPS (TTM) | $-1.62 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $2.41 |
| 52-week low | $1.09 | $1.55 |
| Distance from 52-week high | -61.35% | -8.30% |
| Analyst consensus | none | none |
| Avg. price target upside | +784.57% | +81.00% |
| Average volume | 208.04K | 498.15K |
| Shares outstanding | 76.43M | 55.37M |
| Employees | 118 | 124 |
| Sector | Industrials | Industrials |
| Industry | Agricultural Chemicals | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBUS has outperformed SEER by 13.7 percentage points over the past year.
About Cibus
CBUS stock →Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Industrials · Agricultural Chemicals · 118 employees
About Seer
SEER stock →Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
Industrials · Biotechnology: Laboratory Analytical Instruments · 124 employees
CBUS vs SEER FAQ
Which is bigger, Cibus or Seer?
Cibus (CBUS) is larger, with a market capitalization of $123.81M compared with $122.37M for Seer (SEER).
Which stock has performed better over the past year, CBUS or SEER?
CBUS returned +13.29% over the past 12 months, compared with -0.45% for SEER (price return, excluding dividends). Past performance does not predict future results.
Are Cibus and Seer in the same industry?
Both are in the Industrials sector, but in different industries: Agricultural Chemicals for Cibus and Biotechnology: Laboratory Analytical Instruments for Seer.